Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Ouedraogo JB"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 46
Tytuł:
Major reduction of malaria morbidity with combined vitamin A and zinc supplementation in young children in Burkina Faso: a randomized double blind trial.
Autorzy:
Zeba AN
Sorgho H
Rouamba N
Zongo I
Rouamba J
Guiguemdé RT
Hamer DH
Mokhtar N
Ouedraogo JB
Zeba, Augustin N
Sorgho, Hermann
Rouamba, Noël
Zongo, Issiaka
Rouamba, Jeremie
Guiguemdé, Robert T
Hamer, Davidson H
Mokhtar, Najat
Ouedraogo, Jean-Bosco
Pokaż więcej
Źródło:
Nutrition Journal; 2008, Vol. 7, p7-7, 1p
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Variation in neutrophil levels and artemisinin-based combination therapy efficacy in West-Africa.
Autorzy:
Djimde M; Malaria Research and Training Center (MRTC), University of Sciences of Techniques and Technologies of Bamako (USTTB), Mali.
Kayentao K; Malaria Research and Training Center (MRTC), University of Sciences of Techniques and Technologies of Bamako (USTTB), Mali.
Tshiongo JK; Department of Tropical Medicine, University of Kinshasa (UNIKIN), Kinshasa, Democratic Republic of the Congo.
Fofana B; Malaria Research and Training Center (MRTC), University of Sciences of Techniques and Technologies of Bamako (USTTB), Mali.
Arama C; Malaria Research and Training Center (MRTC), University of Sciences of Techniques and Technologies of Bamako (USTTB), Mali.
Sirima SB; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso.
Ouedraogo JB; Institut des Sciences et des Techniques Bobo Dioulasso (INSTech-Bobo), Burkina Faso.
Beavogui AH; Centre National de Formation et de Recherche en Santé Rurale (CNFRSR), Mafinrinha, Guinea.
Sagara I; Malaria Research and Training Center (MRTC), University of Sciences of Techniques and Technologies of Bamako (USTTB), Mali.
Dicko A; Malaria Research and Training Center (MRTC), University of Sciences of Techniques and Technologies of Bamako (USTTB), Mali.
Mens PF; Amsterdam University Medical Centre, Academic Medical Centre at the University of Amsterdam (AMC), Amsterdam, The Netherlands.
Schallig HD; Amsterdam University Medical Centre, Academic Medical Centre at the University of Amsterdam (AMC), Amsterdam, The Netherlands.
Djimde A; Malaria Research and Training Center (MRTC), University of Sciences of Techniques and Technologies of Bamako (USTTB), Mali.
Pokaż więcej
Źródło:
Journal of infection in developing countries [J Infect Dev Ctries] 2023 Sep 30; Vol. 17 (9), pp. 1337-1345. Date of Electronic Publication: 2023 Sep 30.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antimalarials*/therapeutic use
Malaria, Falciparum*/drug therapy
Artemisinins*/therapeutic use
Malaria*/drug therapy
Neutropenia*/chemically induced
Humans ; Artesunate/therapeutic use ; Neutrophils ; Parasitemia/drug therapy ; Prospective Studies ; Artemether, Lumefantrine Drug Combination/therapeutic use ; Amodiaquine/therapeutic use ; Drug Combinations ; Africa ; Plasmodium falciparum ; Ethanolamines/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Malaria in Burkina Faso: A comprehensive analysis of spatiotemporal distribution of incidence and environmental drivers, and implications for control strategies.
Autorzy:
Bationo C; Aix Marseille Univ, INSERM, IRD, ISSPAM, SESSTIM, UMR1252, Marseille, France.; MIVEGEC, Univ. Montpellier, CNRS, IRD, Montpellier, France.
Cissoko M; Aix Marseille Univ, INSERM, IRD, ISSPAM, SESSTIM, UMR1252, Marseille, France.; Malaria Research and Training Center-Ogobara, Doumbo (MRTC-OD), FMOS-FAPH, Mali-NIAID-ICER, Université des Sciences, des Techniques et des Technologies de Bamako Mali, Bamako, Mali.
Katilé A; Aix Marseille Univ, INSERM, IRD, ISSPAM, SESSTIM, UMR1252, Marseille, France.; Malaria Research and Training Center-Ogobara, Doumbo (MRTC-OD), FMOS-FAPH, Mali-NIAID-ICER, Université des Sciences, des Techniques et des Technologies de Bamako Mali, Bamako, Mali.
Sylla B; Direction des Systèmes d'Information en Santé, Ministère de la Santé du Burkina Faso, Ouagadougou, Burkina Faso.
Ouédraogo A; Programme National de Lutte contre le Paludisme, Ministère de la Santé du Burkina Faso, Ouagadougou, Burkina Faso.
Ouedraogo JB; Programme National de Lutte contre le Paludisme, Ministère de la Santé du Burkina Faso, Ouagadougou, Burkina Faso.
Tougri G; Programme National de Lutte contre le Paludisme, Ministère de la Santé du Burkina Faso, Ouagadougou, Burkina Faso.
Kompaoré SCB; Programme National de Lutte contre le Paludisme, Ministère de la Santé du Burkina Faso, Ouagadougou, Burkina Faso.
Moiroux N; MIVEGEC, Univ. Montpellier, CNRS, IRD, Montpellier, France.; Institut de Recherche en Sciences de la Santé (IRSS), Bobo Dioulasso, Burkina Faso.
Gaudart J; Malaria Research and Training Center-Ogobara, Doumbo (MRTC-OD), FMOS-FAPH, Mali-NIAID-ICER, Université des Sciences, des Techniques et des Technologies de Bamako Mali, Bamako, Mali.; Aix Marseille Univ, INSERM, IRD, ISSPAM, SESSTIM, UMR1252, APHM, Hop Timone, BioSTIC, Biostatistic & ICT, Marseille, France.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Sep 13; Vol. 18 (9), pp. e0290233. Date of Electronic Publication: 2023 Sep 13 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Malaria*/epidemiology
Humans ; Burkina Faso/epidemiology ; Incidence ; Cluster Analysis ; Meteorology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The duration of protection against clinical malaria provided by the combination of seasonal RTS,S/AS01 E vaccination and seasonal malaria chemoprevention versus either intervention given alone.
Autorzy:
Cairns M; International Statistics and Epidemiology Group, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK. .
Barry A; Malaria Research and Training Centre, Bamako, Mali.
Zongo I; Institut de Recherche en Sciences de la Santé, Bobo Dioulasso, Burkina Faso.
Sagara I; Malaria Research and Training Centre, Bamako, Mali.
Yerbanga SR; Institut de Recherche en Sciences de la Santé, Bobo Dioulasso, Burkina Faso.
Diarra M; Malaria Research and Training Centre, Bamako, Mali.
Zoungrana C; Institut de Recherche en Sciences de la Santé, Bobo Dioulasso, Burkina Faso.
Issiaka D; Malaria Research and Training Centre, Bamako, Mali.
Sienou AA; Institut de Recherche en Sciences de la Santé, Bobo Dioulasso, Burkina Faso.
Tapily A; Malaria Research and Training Centre, Bamako, Mali.
Sanogo K; Malaria Research and Training Centre, Bamako, Mali.
Kaya M; Malaria Research and Training Centre, Bamako, Mali.
Traore S; Malaria Research and Training Centre, Bamako, Mali.
Diarra K; Malaria Research and Training Centre, Bamako, Mali.
Yalcouye H; Malaria Research and Training Centre, Bamako, Mali.
Sidibe Y; Malaria Research and Training Centre, Bamako, Mali.
Haro A; Institut de Recherche en Sciences de la Santé, Bobo Dioulasso, Burkina Faso.
Thera I; Malaria Research and Training Centre, Bamako, Mali.
Snell P; Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK.
Grant J; Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.
Tinto H; Institut de Recherche en Sciences de la Santé, Bobo Dioulasso, Burkina Faso.
Milligan P; Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK.
Chandramohan D; Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.
Greenwood B; Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.
Dicko A; Malaria Research and Training Centre, Bamako, Mali.
Ouedraogo JB; Institut de Recherche en Sciences de la Santé, Bobo Dioulasso, Burkina Faso.
Pokaż więcej
Źródło:
BMC medicine [BMC Med] 2022 Oct 07; Vol. 20 (1), pp. 352. Date of Electronic Publication: 2022 Oct 07.
Typ publikacji:
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Malaria*/epidemiology
Malaria*/prevention & control
Malaria Vaccines*
Malaria, Falciparum*/epidemiology
Antibodies, Protozoan ; Chemoprevention ; Humans ; Infant ; Plasmodium falciparum ; Seasons ; Vaccination
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Ethical considerations in deploying triple artemisinin-based combination therapies for malaria: An analysis of stakeholders' perspectives in Burkina Faso and Nigeria.
Autorzy:
Tindana P; Department of Health Policy, Planning and Management, School of Public Health, College of Health Sciences, University of Ghana, Accra, Ghana.
Guissou R; Institut de Recherche en Sciences de la Sante, Bobo-Dioulasso, Burkina Faso.
Bolarinwa OA; Department of Epidemiology and Community Health, University of Ilorin, Ilorin, Nigeria.
Tou F; Institut des Sciences et Techniques, Bobo-Dioulasso, Burkina Faso.
de Haan F; Copernicus Institute of Sustainable Development, Utrecht University, Utrecht, the Netherlands.
Dhorda M; Mahidol Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, Thailand.; Nuffield Department of Medicine, Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, United Kingdom.
Dondorp AM; Mahidol Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, Thailand.; Nuffield Department of Medicine, Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, United Kingdom.
Amaratunga C; Mahidol Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, Thailand.; Nuffield Department of Medicine, Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, United Kingdom.
Mokuolu OA; Department of Paediatrics, University of Ilorin, Ilorin, Nigeria.
Ouedraogo JB; Institut de Recherche en Sciences de la Sante, Bobo-Dioulasso, Burkina Faso.
Cheah PY; Mahidol Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, Thailand.; Nuffield Department of Medicine, Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, United Kingdom.; Nuffield Department of Population Health, The Ethox Centre, University of Oxford, Oxford, United Kingdom.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2022 Sep 09; Vol. 17 (9), pp. e0273249. Date of Electronic Publication: 2022 Sep 09 (Print Publication: 2022).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antimalarials*/pharmacology
Antimalarials*/therapeutic use
Artemisinins*/pharmacology
Artemisinins*/therapeutic use
Malaria*/drug therapy
Malaria, Falciparum*/drug therapy
Malaria, Falciparum*/epidemiology
Burkina Faso ; Child ; Drug Resistance ; Drug Therapy, Combination ; Humans ; Nigeria/epidemiology ; Plasmodium falciparum
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Evaluation of the Pfs25-IMX313/Matrix-M malaria transmission-blocking candidate vaccine in endemic settings.
Autorzy:
Mulamba C; Interventions & Clinical Trials Department, Ifakara Health Institute, P.O. Box 74, Bagamoyo, Tanzania.; Nelson Mandela African Institution of Science and Technology, Tengeru, P. O. Box 447, Arusha, Tanzania.
Williams C; The Jenner Institute, University of Oxford, Roosevelt Drive, Headington, Oxford, OX3 7DQ, UK.
Kreppel K; Nelson Mandela African Institution of Science and Technology, Tengeru, P. O. Box 447, Arusha, Tanzania.
Ouedraogo JB; Institute of Research in Health Sciences, Bobo-Dioulasso, Burkina Faso.
Olotu AI; Interventions & Clinical Trials Department, Ifakara Health Institute, P.O. Box 74, Bagamoyo, Tanzania. .
Pokaż więcej
Źródło:
Malaria journal [Malar J] 2022 Jun 02; Vol. 21 (1), pp. 159. Date of Electronic Publication: 2022 Jun 02.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Malaria Vaccines*
Saponins*
Animals ; Humans ; Insecticide Resistance ; Mosquito Vectors ; Nanoparticles
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Delivery of seasonal malaria chemoprevention with enhanced infection prevention and control measures during the COVID-19 pandemic in Nigeria, Burkina Faso and Chad: a cross-sectional study.
Autorzy:
Ward C; London School of Hygiene and Tropical Medicine, London, UK.
Phillips A; Malaria Consortium, Abuja, Nigeria.
Oresanya O; Malaria Consortium, Abuja, Nigeria.
Olisenekwu G; Oxford Policy Management, Abuja, Nigeria.
Arogunade E; Oxford Policy Management, Abuja, Nigeria.
Moukénet A; Université Cheik Anta Diop, Dakar, Senegal.
Beakgoubé H; Malaria Consortium, N'djamena, Chad.
De Paul Allambademel V; Université De N'djaména, N'djamena, Chad.
Compaoré CS; Malaria Consortium, Ouagadougou, Burkina Faso.
Traoré A; Malaria Consortium, Ouagadougou, Burkina Faso.
Ouedraogo JB; Instech, Bobo Dioulasso, Burkina Faso.
Compaoré YD; Instech, Bobo Dioulasso, Burkina Faso.
Zongo I; Instech, Bobo Dioulasso, Burkina Faso.
Donovan L; Malaria Consortium, London, UK. .
Decola MA; Malaria Consortium, London, UK.
Smith H; International Health Consulting Services Ltd, Wirral, UK.
Baker K; Malaria Consortium, London, UK.
Pokaż więcej
Źródło:
Malaria journal [Malar J] 2022 Mar 24; Vol. 21 (1), pp. 103. Date of Electronic Publication: 2022 Mar 24.
Typ publikacji:
Journal Article
MeSH Terms:
Antimalarials*/therapeutic use
COVID-19*/prevention & control
Malaria*/prevention & control
Burkina Faso/epidemiology ; Chad ; Chemoprevention ; Child ; Child, Preschool ; Cross-Sectional Studies ; Humans ; Infant ; Nigeria/epidemiology ; Pandemics/prevention & control ; Seasons
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Impact of mass administration of azithromycin as a preventive treatment on the prevalence and resistance of nasopharyngeal carriage of Staphylococcus aureus.
Autorzy:
Hema-Ouangraoua S; Centre MURAZ, Bobo-Dioulasso, Burkina Faso.
Tranchot-Diallo J; Centre MURAZ, Bobo-Dioulasso, Burkina Faso.; Université Nazi Boni, Bobo-Dioulasso, Burkina Faso.
Zongo I; Institut de Recherche en Sciences de la Santé (IRSS), Direction Régionale de l'Ouest (DRO), Bobo-Dioulasso, Burkina Faso.
Kabore NF; Centre MURAZ, Bobo-Dioulasso, Burkina Faso.
Nikièma F; Institut de Recherche en Sciences de la Santé (IRSS), Direction Régionale de l'Ouest (DRO), Bobo-Dioulasso, Burkina Faso.
Yerbanga RS; Institut de Recherche en Sciences de la Santé (IRSS), Direction Régionale de l'Ouest (DRO), Bobo-Dioulasso, Burkina Faso.
Tinto H; Institut de Recherche en Sciences de la Santé (IRSS), Direction Régionale de l'Ouest (DRO), Bobo-Dioulasso, Burkina Faso.
Chandramohan D; London School of Hygiene & Tropical Medicine, London, United Kingdom.
Ouedraogo GA; Université Nazi Boni, Bobo-Dioulasso, Burkina Faso.
Greenwood B; London School of Hygiene & Tropical Medicine, London, United Kingdom.
Ouedraogo JB; Institut de Recherche en Sciences de la Santé (IRSS), Direction Régionale de l'Ouest (DRO), Bobo-Dioulasso, Burkina Faso.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2021 Oct 13; Vol. 16 (10), pp. e0257190. Date of Electronic Publication: 2021 Oct 13 (Print Publication: 2021).
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Anti-Bacterial Agents/*therapeutic use
Azithromycin/*therapeutic use
Drug Resistance, Bacterial/*drug effects
Staphylococcal Infections/*prevention & control
Staphylococcus aureus/*drug effects
Anti-Bacterial Agents/administration & dosage ; Antimalarials/administration & dosage ; Antimalarials/therapeutic use ; Azithromycin/administration & dosage ; Child, Preschool ; Female ; Humans ; Infant ; Malaria/prevention & control ; Male ; Nasopharynx/microbiology ; Prevalence ; Staphylococcal Infections/diagnosis ; Staphylococcal Infections/epidemiology ; Staphylococcus aureus/isolation & purification
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Effectiveness of seasonal malaria chemoprevention (SMC) treatments when SMC is implemented at scale: Case-control studies in 5 countries.
Autorzy:
Cairns M; International Statistics and Epidemiology Group, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Ceesay SJ; Medical Research Council Unit The Gambia, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Sagara I; Malaria Research and Training Centre, Bamako, Mali.
Zongo I; Institut de Recherche en Sciences de la Santé, Bobo-Dioulasso, Burkina Faso.
Kessely H; Centre de Support en Santé Internationale, N'Djamena, Chad.
Gamougam K; Centre de Support en Santé Internationale, N'Djamena, Chad.
Diallo A; Universite Cheikh Anta Diop, Dakar, Senegal.
Ogboi JS; Jedima International Health Consult, Lagos, Nigeria.
Moroso D; Malaria Consortium, Kampala, Uganda.
Van Hulle S; Catholic Relief Services, Dakar, Senegal.
Eloike T; Jedima International Health Consult, Lagos, Nigeria.
Snell P; Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Scott S; International Statistics and Epidemiology Group, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Merle C; Special Programme for Research and Training in Tropical Diseases, World Health Organization, Geneva, Switzerland.
Bojang K; Medical Research Council Unit The Gambia, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Ouedraogo JB; Institut de Recherche en Sciences de la Santé, Bobo-Dioulasso, Burkina Faso.
Dicko A; Malaria Research and Training Centre, Bamako, Mali.
Ndiaye JL; Universite Cheikh Anta Diop, Dakar, Senegal.; University of Thies, Thies, Senegal.
Milligan P; Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Pokaż więcej
Źródło:
PLoS medicine [PLoS Med] 2021 Sep 08; Vol. 18 (9), pp. e1003727. Date of Electronic Publication: 2021 Sep 08 (Print Publication: 2021).
Typ publikacji:
Journal Article; Meta-Analysis; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Communicable Disease Control*
Seasons*
Amodiaquine/*therapeutic use
Antimalarials/*therapeutic use
Malaria, Falciparum/*prevention & control
Plasmodium falciparum/*drug effects
Pyrimethamine/*therapeutic use
Sulfadoxine/*therapeutic use
Africa, Western/epidemiology ; Age Factors ; Amodiaquine/adverse effects ; Antimalarials/adverse effects ; Case-Control Studies ; Child, Preschool ; Drug Combinations ; Female ; Humans ; Incidence ; Infant ; Malaria, Falciparum/diagnosis ; Malaria, Falciparum/epidemiology ; Malaria, Falciparum/parasitology ; Male ; Parasite Load ; Plasmodium falciparum/growth & development ; Program Evaluation ; Pyrimethamine/adverse effects ; Risk Assessment ; Risk Factors ; Sulfadoxine/adverse effects ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Combining malaria vaccination with chemoprevention: a promising new approach to malaria control.
Autorzy:
Greenwood B; London School of Hygiene and Tropical Medicine, London, UK. .
Cairns M; London School of Hygiene and Tropical Medicine, London, UK.
Chaponda M; Tropical Diseases Research Centre, Ndola, Zambia.
Chico RM; London School of Hygiene and Tropical Medicine, London, UK.
Dicko A; Malaria Research and Training Centre, University of Science, Techniques and Technology of Bamako, Bamako, Mali.
Ouedraogo JB; Institut de Recherche en Sciences de La Santé, Bobo-Dioulasso, Burkina Faso.
Phiri KS; School of Public Health, Kamuzu University of Health Sciences, Blantyre, Malawi.
Ter Kuile FO; Liverpool School of Tropical Medicine, Liverpool, UK.
Chandramohan D; London School of Hygiene and Tropical Medicine, London, UK.
Pokaż więcej
Źródło:
Malaria journal [Malar J] 2021 Sep 06; Vol. 20 (1), pp. 361. Date of Electronic Publication: 2021 Sep 06.
Typ publikacji:
Letter
MeSH Terms:
Chemoprevention/*statistics & numerical data
Communicable Disease Control/*methods
Malaria/*prevention & control
Malaria Vaccines/*therapeutic use
Vaccination/*statistics & numerical data
Communicable Disease Control/statistics & numerical data ; Humans
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
To what extent are the antimalarial markets in African countries ready for a transition to triple artemisinin-based combination therapies?
Autorzy:
de Haan F; Copernicus Institute of Sustainable Development, Utrecht University, Utrecht, The Netherlands.
Bolarinwa OA; College of Health Sciences, University of Ilorin, Ilorin, Nigeria.
Guissou R; Institut de Recherche en Sciences de la Sante, Bobo-Dioulasso, Burkina Faso.
Tou F; Institut des Sciences et Techniques, Bobo-Dioulasso, Burkina Faso.
Tindana P; School of Public Health, College of Health Sciences, University of Ghana, Accra, Ghana.
Boon WPC; Copernicus Institute of Sustainable Development, Utrecht University, Utrecht, The Netherlands.
Moors EHM; Copernicus Institute of Sustainable Development, Utrecht University, Utrecht, The Netherlands.
Cheah PY; Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.; Center for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Dhorda M; Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.; Center for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Dondorp AM; Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.; Center for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Ouedraogo JB; Institut de Recherche en Sciences de la Sante, Bobo-Dioulasso, Burkina Faso.; Institut des Sciences et Techniques, Bobo-Dioulasso, Burkina Faso.
Mokuolu OA; College of Health Sciences, University of Ilorin, Ilorin, Nigeria.
Amaratunga C; Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.; Center for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2021 Aug 31; Vol. 16 (8), pp. e0256567. Date of Electronic Publication: 2021 Aug 31 (Print Publication: 2021).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Marketing*
Antimalarials/*therapeutic use
Artemisinins/*therapeutic use
Malaria/*drug therapy
Burkina Faso ; Drug Approval ; Drug Therapy, Combination ; Focus Groups ; Humans ; Nigeria ; Patient Acceptance of Health Care ; Practice Guidelines as Topic ; Prescription Drugs ; Private Sector ; Public Sector ; Social Control, Formal
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Nutritional status in young children prior to the malaria transmission season in Burkina Faso and Mali, and its impact on the incidence of clinical malaria.
Autorzy:
de Wit M; London School of Hygiene and Tropical Medicine, London, UK. .
Cairns M; London School of Hygiene and Tropical Medicine, London, UK.
Compaoré YD; Institut de Recherche en Sciences de La Santé, Bobo-Dioulasso, Burkina Faso.
Sagara I; Malaria Research and Training Centre, University of Science, Techniques, and Technologies of Bamako, Bamako, Mali.
Kuepfer I; London School of Hygiene and Tropical Medicine, London, UK.
Zongo I; Institut de Recherche en Sciences de La Santé, Bobo-Dioulasso, Burkina Faso.
Barry A; Malaria Research and Training Centre, University of Science, Techniques, and Technologies of Bamako, Bamako, Mali.
Diarra M; Malaria Research and Training Centre, University of Science, Techniques, and Technologies of Bamako, Bamako, Mali.
Tapily A; Malaria Research and Training Centre, University of Science, Techniques, and Technologies of Bamako, Bamako, Mali.
Coumare S; Malaria Research and Training Centre, University of Science, Techniques, and Technologies of Bamako, Bamako, Mali.
Thera I; Malaria Research and Training Centre, University of Science, Techniques, and Technologies of Bamako, Bamako, Mali.
Nikiema F; Institut de Recherche en Sciences de La Santé, Bobo-Dioulasso, Burkina Faso.
Yerbanga RS; Institut de Recherche en Sciences de La Santé, Bobo-Dioulasso, Burkina Faso.
Guissou RM; Institut de Recherche en Sciences de La Santé, Bobo-Dioulasso, Burkina Faso.
Tinto H; Institut de Recherche en Sciences de La Santé, Bobo-Dioulasso, Burkina Faso.
Dicko A; Malaria Research and Training Centre, University of Science, Techniques, and Technologies of Bamako, Bamako, Mali.
Chandramohan D; London School of Hygiene and Tropical Medicine, London, UK.
Greenwood B; London School of Hygiene and Tropical Medicine, London, UK.
Ouedraogo JB; Institut de Recherche en Sciences de La Santé, Bobo-Dioulasso, Burkina Faso.
Pokaż więcej
Źródło:
Malaria journal [Malar J] 2021 Jun 22; Vol. 20 (1), pp. 274. Date of Electronic Publication: 2021 Jun 22.
Typ publikacji:
Journal Article
MeSH Terms:
Nutritional Status*
Antimalarials/*administration & dosage
Azithromycin/*administration & dosage
Malaria/*epidemiology
Malnutrition/*epidemiology
Burkina Faso/epidemiology ; Child, Preschool ; Female ; Humans ; Incidence ; Infant ; Malaria/transmission ; Male ; Mali/epidemiology ; Malnutrition/classification ; Seasons
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Immunogenicity and Reactogenicity of 13-Valent Pneumococcal Conjugate Vaccine Among Infants, Toddlers, and Children in Western Burkina Faso: Results From a Clinical Trial of Alternative Immunization Schedules.
Autorzy:
Moïsi JC; Agence de Médecine Préventive, Paris, France.
Yaro S; Centre Muraz, Bobo-Dioulasso, Burkina Faso.
Kroman SS; Agence de Médecine Préventive, Abidjan, Côte d'Ivoire.
Gouem C; Centre Muraz, Bobo-Dioulasso, Burkina Faso.
Bayane D; Ministry of Health, Ouagadougou, Burkina Faso.
Ganama S; Ministry of Health, Ouagadougou, Burkina Faso.
Meda B; Agence de Medecine Preventive, Bobo-Dioulasso, Burkina Faso.
Nacro B; Centre Hospitalier Sanou Sourou, Bobo-Dioulasso, Burkina Faso.
Njanpop-Lafourcade BM; Agence de Médecine Préventive, Paris, France.
Ouangraoua S; Centre Muraz, Bobo-Dioulasso, Burkina Faso.
Ouedraogo I; Agence de Medecine Preventive, Bobo-Dioulasso, Burkina Faso.
Sakande S; Agence de Medecine Preventive, Bobo-Dioulasso, Burkina Faso.
Sawadogo F; Agence de Medecine Preventive, Bobo-Dioulasso, Burkina Faso.
Zida S; Centre Muraz, Bobo-Dioulasso, Burkina Faso.
Ouedraogo JB; Centre Muraz, Bobo-Dioulasso, Burkina Faso.
Gessner BD; Agence de Médecine Préventive, Paris, France.
Pokaż więcej
Źródło:
Journal of the Pediatric Infectious Diseases Society [J Pediatric Infect Dis Soc] 2019 Nov 06; Vol. 8 (5), pp. 422-432.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Immunization Schedule*
Immunogenicity, Vaccine*
Pneumococcal Vaccines/*immunology
Age Factors ; Antibodies, Bacterial/blood ; Burkina Faso ; Child, Preschool ; Female ; Humans ; Immunization, Secondary ; Immunoglobulin G/blood ; Immunoglobulin G/immunology ; Infant ; Male ; Opsonin Proteins/blood ; Opsonin Proteins/immunology ; Phagocytosis/immunology ; Pneumococcal Infections/prevention & control ; Pneumococcal Vaccines/administration & dosage ; Serogroup ; Streptococcus pneumoniae ; Vaccines, Conjugate/administration & dosage ; Vaccines, Conjugate/immunology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 46

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies